相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Genome-wide mutation analysis in precancerous lesions of endometrial carcinoma
Lihong Li et al.
JOURNAL OF PATHOLOGY (2021)
CHD4 Predicts Aggressiveness in PTC Patients and Promotes Cancer Stemness and EMT in PTC Cells
Poyil Pratheeshkumar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
The NuRD chromatin-remodeling complex enzyme CHD4 prevents hypoxia-induced endothelial Ripk3 transcription and murine embryonic vascular rupture
Sarah Colijn et al.
CELL DEATH AND DIFFERENTIATION (2020)
The Histone Deacetylase Inhibitor Romidepsin Spares Normal Tissues While Acting as an Effective Radiosensitizer in Bladder Tumors in Vivo
Salome Paillas et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2020)
Epigenetics of colorectal cancer: biomarker and therapeutic potential
Gerhard Jung et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair
Tianyun Hou et al.
NUCLEIC ACIDS RESEARCH (2020)
Whole-Exome Sequencing of Matched Primary and Metastatic Papillary Thyroid Cancer
Tariq Masoodi et al.
THYROID (2020)
CHD4 mediates proliferation and migration of non-small cell lung cancer via the RhoA/ROCK pathway by regulating PHF5A
Nuo Xu et al.
BMC CANCER (2020)
CHD4/NuRD complex regulates complement gene expression and correlates with CD8 T cell infiltration in human hepatocellular carcinoma
Simin Shao et al.
CLINICAL EPIGENETICS (2020)
TP63, SOX2, and KLF5 Establish a Core Regulatory Circuitry That Controls Epigenetic and Transcription Patterns in Esophageal Squamous Cell Carcinoma Cell Lines
Yan-Yi Jiang et al.
GASTROENTEROLOGY (2020)
CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors
Yijie Wang et al.
CANCER RESEARCH (2020)
Histone deacetylase inhibition prevents the growth of primary and metastatic osteosarcoma
Jeremy J. McGuire et al.
INTERNATIONAL JOURNAL OF CANCER (2020)
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice
Hara Afaloniati et al.
ONCOTARGETS AND THERAPY (2020)
Chromatin restriction by the nucleosome remodeler Mi-2β and functional interplay with lineage-specific transcription regulators control B-cell differentiation
Toshimi Yoshida et al.
GENES & DEVELOPMENT (2019)
Immunoepigenetics Combination Therapies: An Overview of the Role of HDACs in Cancer Immunotherapy
Debarati Banik et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Over-Expression of CHD4 Is an Independent Biomarker of Poor Prognosis in Patients with Rectal Cancers Receiving Concurrent Chemoradiotherapy
Hui-Ching Wang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
Berkley E. Gryder et al.
NATURE GENETICS (2019)
Cancer statistics, 2019
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2019)
Identification of CHD4-β1 integrin axis as a prognostic marker in triple-negative breast cancer using next-generation sequencing and bioinformatics
Fu Ou-Yang et al.
LIFE SCIENCES (2019)
Ovarian Cancer Statistics, 2018
Lindsey A. Torre et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Genome-wide identification of transcription factors that are critical to non-small cell lung cancer
Da-Lin Zhang et al.
CANCER LETTERS (2018)
Pharmacological or transcriptional inhibition of both HDAC1 and 2 leads to cell cycle blockage and apoptosis via p21Waf1/Cip1 and p19INK4d upregulation in hepatocellular carcinoma
Hengyu Zhou et al.
CELL PROLIFERATION (2018)
CHD4-mediated loss of E-cadherin determines metastatic ability in triple negative breast cancer cells
Chi-Wen Luo et al.
EXPERIMENTAL CELL RESEARCH (2018)
CHD3 and CHD4 recruitment and chromatin remodeling activity at DNA breaks is promoted by early poly(ADP-ribose)-dependent chromatin relaxation
Rebecca Smith et al.
NUCLEIC ACIDS RESEARCH (2018)
Combined inhibition of BET proteins and class I HDACs synergistically induces apoptosis in urothelial carcinoma cell lines
Alexander S. Hoelscher et al.
CLINICAL EPIGENETICS (2018)
Epigenetics in ovarian cancer: premise, properties, and perspectives
Qilian Yang et al.
MOLECULAR CANCER (2018)
Atypical GATA transcription factor TRPS1 represses gene expression by recruiting CHD4/NuRD(MTA2) and suppresses cell migration and invasion by repressing TP63 expression
Yuzhi Wang et al.
ONCOGENESIS (2018)
Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2
Qun Chen et al.
CLINICAL CANCER RESEARCH (2018)
Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells
H. Ding et al.
LEUKEMIA (2017)
Reactive Oxygen Species-Mediated Synergism of Fenretinide and Romidepsin in Preclinical Models of T-cell Lymphoid Malignancies
Monish R. Makena et al.
MOLECULAR CANCER THERAPEUTICS (2017)
CHD4 Has Oncogenic Functions in Initiating and Maintaining Epigenetic Suppression of Multiple Tumor Suppressor Genes
Limin Xia et al.
CANCER CELL (2017)
Inhibition of class I histone deacetylases by romidepsin potently induces Epstein-Barr virus lytic cycle and mediates enhanced cell death with ganciclovir
Kwai Fung Hui et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Acetyltransferase p300 collaborates with chromodomain helicase DNA-binding protein 4 (CHD4) to facilitate DNA double-strand break repair
Wenjing Qi et al.
MUTAGENESIS (2016)
HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma
Hong Zheng et al.
CLINICAL CANCER RESEARCH (2016)
Helicase CHD4 is an epigenetic coregulator of PAX3-FOXO1 in alveolar rhabdomyosarcoma
Maria Bohm et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Pingping Zhu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
lnc-β-Catm elicits EZH2-dependent β-catenin stabilization and sustains liver CSC self-renewal
Pingping Zhu et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2016)
Preclinical Pharmacologic Evaluation of Pralatrexate and Romidepsin Confirms Potent Synergy of the Combination in a Murine Model of Human T-cell Lymphoma
Salvia Jain et al.
CLINICAL CANCER RESEARCH (2015)
Defeating EpCAM+ liver cancer stem cells by targeting chromatin remodeling enzyme CHD4 in human hepatocellular carcinoma
Kouki Nio et al.
JOURNAL OF HEPATOLOGY (2015)
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics
Paul Geeleher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Romidepsin for the Treatment of Peripheral T-Cell Lymphoma
Swaminathan P. Iyer et al.
ONCOLOGIST (2015)
Predicting Response to Histone Deacetylase Inhibitors Using High-Throughput Genomics
Paul Geeleher et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Combination of proteasome and class I HDAC inhibitors induces apoptosis of NPC cells through an HDAC6-independent ER stress-induced mechanism
Kwai Fung Hui et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The NuRD complex cooperates with DNMTs to maintain silencing of key colorectal tumor suppressor genes
Y. Cai et al.
ONCOGENE (2014)
ZFHX4 Interacts with the NuRD Core Member CHD4 and Regulates the Glioblastoma Tumor-Initiating Cell State
Yakov Chudnovsky et al.
CELL REPORTS (2014)
Chromodomain Helicase DNA-binding Protein 4 (CHD4) Regulates Homologous Recombination DNA Repair, and Its Deficiency Sensitizes Cells to Poly(ADP-ribose) Polymerase (PARP) Inhibitor Treatment
Mei-Ren Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genes
Matthieu Le Gallo et al.
NATURE GENETICS (2012)
The TWIST/Mi2/NuRD protein complex and its essential role in cancer metastasis
Junjiang Fu et al.
CELL RESEARCH (2011)
Regulation of DNA-damage responses and cell-cycle progression by the chromatin remodelling factor CHD4
Sophie E. Polo et al.
EMBO JOURNAL (2010)
The chromatin-remodeling factor CHD4 coordinates signaling and repair after DNA damage
Dorthe Helena Larsen et al.
JOURNAL OF CELL BIOLOGY (2010)
The human Mi-2/NuRD complex and gene regulation
S. A. Denslow et al.
ONCOGENE (2007)
Histone deacetylase inhibitor, FK228, induces apoptosis and suppresses cell proliferation of human glioblastoma cells in vitro and in vivo
H Sawa et al.
ACTA NEUROPATHOLOGICA (2004)
Deacetylation of p53 modulates its effect on cell growth and apoptosis
JY Luo et al.
NATURE (2000)
分享论文
